GovChime
Notice ID: f7ce7fa8105d4fb9977444970d785944Solicitation

NanoBret Kinase Assay

Archived on September 14, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
9:00 AM UTC−04:00
Posted
September 7, 2022
Notice type
Solicitation
NAICS
541380: Testing Laboratories and Services
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Sep 9, 2025

Identifiers

Solicitation number
75N95022Q00552
Notice ID
f7ce7fa8105d4fb9977444970d785944

Description

The National Center for Advancing Translational Sciences (NCATS) is a part of the NIH, with a mission to catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. (NCATS) would like to acquire services from Reaction to test 100 compounds against select kinases in a cellular NanoBret Assay.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N95022Q00552
  1. Solicitation

Award typically follows within 30–90 days after the response deadline. (estimate)

  1. SolicitationCurrentSep 7, 2022

    NanoBret Kinase Assay

    Notice f7ce7fa8105d4fb9977444970d785944 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95022Q00552

Archive Date

Sep 14, 2022

Office Address

Bethesda, MD, 20892